Chemical Structure (Lac04 0002 01)
Lacosamide Injection, Solution
Product Images NDC 25021-791
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 25021-791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Lac04 0002 02)
This appears to be a chart or a table showing some percentage values and medications used for seizure reduction. The text is not entirely readable and some parts of it are symbols or non-English characters. Therefore, it is not possible to generate a useful description.*
Figure 2 (Lac04 0002 03)
This is a chart displaying the responder rate (equal to or greater) for patients taking placebo and lacosamide at different dosages. The data shown includes the number of patients in each group (N) and the percent of patients who experienced improvement or worsening. The chart shows that higher dosages of lacosamide generally resulted in higher responder rates.*
Package Label – Principal Display Panel – Vial Label (Lac04 0002 04)
The text contains information regarding a drug with code number GO/DRUGS/557. The drug is an injection with the name Lacosam, and it is listed as USP with a concentration of 200 mg per 20 mL. The NDC number for the drug is 25021-791-20. Other characters and numbers seem unrelated and do not provide additional useful information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
